EirGenix Profit Margin

The latest profit margin for 6589.TWO is -65.89% as of March 2026. That compares with -77.37% in the prior-year period — up 14.8% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside EirGenix's historical trend and sector peers before judging valuation or financial health.

Over the past year, 6589.TWO's profit margin moved from -77.37% to -65.89% — a 14.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in EirGenix's valuation or profitability profile.

Against Healthcare companies, 6589.TWO currently prints -65.89% for profit margin, while the sector average sits near 21.34%. That is roughly 408.9% below the sector mean. Large gaps often invite a closer look at EirGenix's growth, margins, and balance sheet.

Profit Margin shows how effectively EirGenix converts resources into returns. At -65.89%, 6589.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -77.37% in the prior-year period — up 14.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 6589.TWO's profit margin (-65.89%), review year-over-year change from -77.37%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.